IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,232,038,000 | +139.9% | 26,250,000 | 0.0% | 31.71% | +72.4% |
| Q2 2020 | $930,300,000 | +181.7% | 26,250,000 | +7.1% | 18.39% | +65.0% |
| Q1 2020 | $330,260,000 | -36.3% | 24,500,000 | 0.0% | 11.15% | -26.8% |
| Q4 2019 | $518,420,000 | +86.2% | 24,500,000 | +16.7% | 15.22% | +31.0% |
| Q3 2019 | $278,460,000 | -4.4% | 21,000,000 | 0.0% | 11.62% | +15.4% |
| Q2 2019 | $291,270,000 | -14.4% | 21,000,000 | +18.5% | 10.07% | -31.6% |
| Q1 2019 | $340,295,000 | +34.6% | 17,714,461 | 0.0% | 14.72% | -2.6% |
| Q4 2018 | $252,785,000 | -31.5% | 17,714,461 | 0.0% | 15.11% | -10.8% |
| Q3 2018 | $368,992,000 | -12.0% | 17,714,461 | 0.0% | 16.94% | +5.0% |
| Q2 2018 | $419,301,000 | +69.4% | 17,714,461 | +4.6% | 16.14% | +36.6% |
| Q1 2018 | $247,486,000 | -7.6% | 16,939,461 | 0.0% | 11.82% | -31.9% |
| Q4 2017 | $267,827,000 | +26.1% | 16,939,461 | +8.5% | 17.36% | +5.4% |
| Q3 2017 | $212,358,000 | +129.3% | 15,614,461 | +48.9% | 16.47% | +40.9% |
| Q2 2017 | $92,610,000 | +36.5% | 10,488,076 | 0.0% | 11.69% | +34.9% |
| Q1 2017 | $67,858,000 | +99.5% | 10,488,076 | +9.7% | 8.67% | +26.1% |
| Q4 2016 | $34,019,000 | +42.2% | 9,564,140 | +25.1% | 6.87% | +63.8% |
| Q3 2016 | $23,922,000 | +20.1% | 7,644,977 | -15.2% | 4.20% | -5.2% |
| Q2 2016 | $19,916,000 | +658.4% | 9,010,857 | +757.8% | 4.42% | +383.1% |
| Q1 2016 | $2,626,000 | – | 1,050,457 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|